Literature DB >> 23136325

The adult ADHD self-report scale for screening for adult attention deficit-hyperactivity disorder (ADHD).

Joseph L Hines1, Tonya S King, William J Curry.   

Abstract

BACKGROUND: Adult attention deficit-hyperactivity disorder (ADHD) is underdiagnosed in the primary care setting despite 3% to 6% of adults having ADHD-like symptoms. The Adult ADHD Self-Report Scale-V1.1 (ASRS-V1.1) is a validated, 6-question screen for adult ADHD. Our purpose was to analyze this tool for evaluating patients in a busy primary care setting.
METHODS: The ASRS-V1.1 was administered to patients in 8 busy primary care practices. All with a positive score and a random sample of those with a negative screening score were asked to complete the Conners' Adult ADHD Rating Scale Self Report-Short Version. Each was administered within the clinic setting during the same session. Sensitivity, specificity, and positive/negative predictive values were calculated. Data were evaluated for site-specific differences.
RESULTS: It took an average of 54.3 seconds (range, 22-252 seconds) to complete the ASRS-V1.1. There was an inconsistency-adjusted sensitivity of 1.0, a specificity of 0.71, a positive predictive value of 0.52, and a negative predictive value of 1.0. No site-specific differences were found.
CONCLUSIONS: Because of its ease of use, short time to administer, high sensitivity, and moderate specificity, the ASRS-V1.1 is an effective adult ADHD screening to guide further evaluations for ADHD.

Entities:  

Mesh:

Year:  2012        PMID: 23136325     DOI: 10.3122/jabfm.2012.06.120065

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  18 in total

1.  Impaired visuomotor adaptation in adults with ADHD.

Authors:  Laura B F Kurdziel; Katherine Dempsey; Mackenzie Zahara; Eve Valera; Rebecca M C Spencer
Journal:  Exp Brain Res       Date:  2015-01-08       Impact factor: 1.972

2.  Distribution and Within-Family Specificity of Quantitative Autistic Traits in Patients with Neurofibromatosis Type I.

Authors:  John N Constantino; Yi Zhang; Kieran Holzhauer; Sayli Sant; Kyna Long; Alicia Vallorani; Leena Malik; David H Gutmann
Journal:  J Pediatr       Date:  2015-06-04       Impact factor: 4.406

Review 3.  Treatment of adult ADHD: a clinical perspective.

Authors:  Josh Geffen; Kieran Forster
Journal:  Ther Adv Psychopharmacol       Date:  2017-10-25

4.  Visual function and color vision in adults with Attention-Deficit/Hyperactivity Disorder.

Authors:  Soyeon Kim; Samantha Chen; Rosemary Tannock
Journal:  J Optom       Date:  2013-08-16

5.  The Adult ADHD Self-Report Scale (ASRS): utility in college students with attention-deficit/hyperactivity disorder.

Authors:  Sarah Gray; Steven Woltering; Karizma Mawjee; Rosemary Tannock
Journal:  PeerJ       Date:  2014-03-25       Impact factor: 2.984

Review 6.  Mental health in adolescents with Type 1 diabetes: results from a large population-based study.

Authors:  Børge Sivertsen; Keith J Petrie; Ane Wilhelmsen-Langeland; Mari Hysing
Journal:  BMC Endocr Disord       Date:  2014-10-10       Impact factor: 2.763

7.  Colour vision in ADHD: part 1--testing the retinal dopaminergic hypothesis.

Authors:  Soyeon Kim; Mohamed Al-Haj; Samantha Chen; Stuart Fuller; Umesh Jain; Marisa Carrasco; Rosemary Tannock
Journal:  Behav Brain Funct       Date:  2014-10-24       Impact factor: 3.759

8.  Adult ADHD: Risk Factor for Dementia or Phenotypic Mimic?

Authors:  Brandy L Callahan; Daniel Bierstone; Donald T Stuss; Sandra E Black
Journal:  Front Aging Neurosci       Date:  2017-08-03       Impact factor: 5.750

9.  Performance of the Adult ADHD Self-Report Scale-v1.1 in Adults with Major Depressive Disorder.

Authors:  Boadie W Dunlop; Ruizhe Wu; Kathleen Helms
Journal:  Behav Sci (Basel)       Date:  2018-03-29

10.  Increased default-mode variability is related to reduced task-performance and is evident in adults with ADHD.

Authors:  Athanasia M Mowinckel; Dag Alnæs; Mads L Pedersen; Sigurd Ziegler; Mats Fredriksen; Tobias Kaufmann; Edmund Sonuga-Barke; Tor Endestad; Lars T Westlye; Guido Biele
Journal:  Neuroimage Clin       Date:  2017-03-30       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.